Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danlou Tablet for stable angina in coronary heart disease
ChiCTR1900028068Phase 4Not yet recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Jan 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of danlou in coronary arteriosclerosis and stable angina (2 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Frequency of angina pectoris attack and Outcome of safety. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
danlou
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR1900028068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028068.